MGI Tech Showcases World-First High-Throughput Automated Sample Transfer Processing System at MEDICA 2021
By LabMedica International staff writers Posted on 17 Nov 2021 |
MGI Tech Co., Ltd. (Shenzhen, China) showcased some of its latest laboratory automation systems for sample transfer, sample extraction and library preparation, including the world’s first high-throughput automated sample transfer processing system, at MEDICA 2021.
MGI’s automation systems on display at the event included the MGISP-960, MGISP-NE384, MGISTP-7000 and MGISTP-3000 - all of which can be harnessed in the fight against the COVID-19 pandemic. MGISTP-7000 is a high-throughput automated sample transfer processing system that was specially designed for nucleic acid detection in the COVID-19 pandemic. The system integrates tube decapping, tube recapping, barcode identification, automated liquid transfer and negative pressure protection. With just a single click, the MGISTP-7000 can load original samples with caps and transfer up to 192 potential contagious samples from airtight sample tubes or plain tubes to 96-well microplates, with zero human contact during the process in 40 minutes. This first-of-its-kind automation system has already received CE marking and been rolled out in laboratories in Europe.
MGISTP-3000 is the benchtop version of the STP7000, offering automated sample transfer processing with tube decapping, tube recapping, barcode identification, automated liquid transfer and negative pressure protection for up to 96 samples. This compact desktop system is capable of processing 1,000 to 10,000 samples per day with just one click. MGISP-NE384 is a high-throughput automated nucleic acid extractor that adopts magnetic rod technology. Together with a nucleic acid extraction kit, MGISP-NE384 is able to extract and purify nucleic acid from 96/192/288/384 samples. HEPA filtration system and UV lamp ensure a safe working environment for nucleic acid extraction and lab technicians. MGISP-NE384 is particularly beneficial for labs looking to improve daily testing capacity for COVID-19. One single unit can process 10,000 samples per day, and the daily testing capacity of 10 units can reach up to 1 million if 10 samples are mixed in one tube.
MGISP-960 is a highly efficient, widely used automated sample preparation system equipped with comprehensive functions, economic and efficient operation and comprehensive protection in a truly open platform. A flexible, fully automated workstation with 96-channel pipette, which can be used for COVID sample extraction and PCR set-up. MGISP-960 has also validated plenty of library kits including WES, WGS, RNA and more. Meanwhile, the device's fully automatic operation design can realize unmanned processes and be customized according to the user's specific needs.
MGI has already combined the MGISP-960, MGISP-NE384 and MGISTP-7000 in a single automated, integrated container laboratory that significantly improves testing capacity for large-scale COVID-19 nucleic acid testing. The container is an integrated platform that automates the management of the entire testing process, from barcode identification to sample dispatch, nucleic acid extraction, fluorescence quantitative PCR testing, and report distribution. A game-changing system, MGI's container laboratory has already been embraced by companies across Europe.
Related Links:
MGI Tech Co., Ltd.
Latest Molecular Diagnostics News
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders
- Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access
- Respiratory and Throat Infection PCR Test Detects Multiple Pathogens with Overlapping Symptoms
- Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis
- First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety
- Fluid Biomarker Test Detects Neurodegenerative Diseases Before Symptoms Appear